Our results are consistent with the findings of a systematic review by Strippoli et al. [36], which indicated maintaining low Hb levels in CKD patients is associated with decreased risk of hypertension and death when compared with the high Hb levels. The gene discussed is GSTM1; the disease is Hypertension.